To the best of our knowledge, this is the first study assessing the diagnostic value of atrial dimensions and serum NT-proBNP to differentiate between ARVC and the athlete’s heart, integrating these findings into a novel diagnostic score to better discriminate between both phenocopies. The gene discussed is NPPB; the disease is arrhythmogenic right ventricular cardiomyopathy.